Late-onset hypogonadism. Diagnostical and treatment landmarks
DOI:
https://doi.org/10.52556/2587-3873.2024.5(102).21Keywords:
age-related hypogonadism, „late-onset” hypogonadism, functional hypogonadism, hormone replacementtherapyAbstract
Late-onset hypogonadism (LOH) is the most controversial form of hypogonadism and an unsolved problem. Its prevalence is unknown, it is estimated as being at least 1 in 5 men after 40 years, and about 80% of those with comorbidities may have hypogonadism. LOH does not have age-defined criteria and may be included in its start-out and developing mechanisms elements of primary hypogonadism due to insufficient testicular function and secondary. When preparing this article, the reviews of 40 analytical studies and international guidelines of the European Academy of Andrology and the Societies of Endocrinology and Urology were consulted. This type of hypogonadism is dependent on the age and men’s health status. Decreased testosterone levels can be the result of chronic disease, diabetes, organ failure, or obesity. Or because of the presence of chronic systemic inflammation. Older patients with signs of testosterone deficiency need an individual approach to establish the presence of a reversible/ functional form of hypogonadism that can be ameliorated with other remedies than testosterone replacement therapy. After clinical and biochemical confirmation of hypogonadism, testosterone treatment recommended recommended only with an evaluation of potential benefits and risks.
References
1. POZARSKIS, A., POZARSKA, R., BARANOVSKA, L. Late onset hypogonadism affects only elderly men with co-morbidities. In: The Journal of Sexual Medicine. 2022, nr. 19, pp. PS75. https://doi.org/10.1016/j.jsxm.2022.10.009
2. BUVAT, J., MAGGI, M., GUAY, A., TORRES, L. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. In: J Sex Med. 2013, nr. 10, pp. 245-284. Online ISSN:1743-6109 https://doi.org/10.1111/j.1743-6109.2012.02783.x
3. CARONIA, L.M., DWYER, A.A., HAYDEN, D. et al. Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism. In: Clin Endocrinol. 2013, nr. 78, pp. 291-296. https://doi.org/10.1111/j.1365-2265.2012.04486.x
4. CORONA, G., GOULIS, D.G., HUHTANIEMI, I. et al. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males. In: Andrology. 2020, nr. 8, pp. 970-987. https://doi.org/10.1111/andr.12770
5. CORONA, G., RASTRELLI, G., FERRI, S., SFORZA, A., MAGGI, M. Testosterone and Sexual Function. In: HOHL, A. (eds) Testosterone. Springer 2023. Cham. https://doi.org/10.1007/978-3-031-31501-5_17
6. CORONA, G., TORRES, L., MAGGI, M. Testosterone Therapy: What We Have Learned From Trials. In: The Journal of Sexual Medicine. 2020, nr. 17(3), pp. 447-460. https://doi.org/10.1016/j.jsxm.2019.11.270
7. FELDMAN, H.A., LONGCOPE, C., DERBY, C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. In: J Clin Endocrinol Metab. 2002, nr. 87, pp. 589-598. EISSN 1945-7197 https://doi.org/10.1210/jcem.87.2.8201
8. FULOP, T., LARBI, A., PAWELEC, G., KHALIL, A. et al. Immunology of aging: the birth of inflammaging. In: Clin Rev Allergy Immunol. 2023, nr. 64, pp. 109-122. https://doi.org/10.1007/s12016-021-08899-6
9. HACKETT, G., KIRBY, M., EDWARDS, D. et al. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, with Statements for UK Practice. In: The Journal of Sexual Medicine. 2017, nr. 14(12), pp. 1504-1523. https://doi.org/10.1016/j.jsxm.2017.10.067
10. GHENCIU, V., COROI, L., ARIAN, I.U, et al. The role of bariatric surgery in the treatment of male infertility and morbid obesity. In: New horizons in urology: The 8th congress on urology, dialysis and kidney transplant from Republic of Moldova with international participation, 7-9 iunie 2023, Chişinău: Taicom (Ridgeone Group). 2023, pp. 378. ISSN 2558-815X.
11. GIAGULLI, V.A., CASTELLANA, M., LISCO, G., TRIGGIANI, V. Critical evaluation of different available guidelines for late-onset hypogonadism. In: Andrology. 2020, nr. 8, pp. 1628-1641. https://doi.org/10.1111/andr.12850
12. CUNNINGHAM, G.R., ELLENBERG, S.S., BHASIN, S. et al. Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial. In: The Journal of Clinical Endocrinology & Metabolism. 2019, nr. 104(12), pp. 6238-6246. https://doi.org/10.1210/jc.2019-00806
13. GROSSMANN, M., MATSUMOTO, A.A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. In: The Journal of Clinical Endocrinology & Metabolism. 2017, nr. 102(3), pp. 1067-1075. https://doi.org/10.1210/jc.2016-3580
14. HUHTANIEMI, I. Late-onset hypogonadism: Current concepts and controversies of pathogenesis, diagnosis and treatment. In: Asian Journal of Andrology. 2014, nr. 16(2), pp. 192-202. https://doi.org/10.4103/1008-682X.122336
15. HUIJBEN, M., et al. Clomiphene citrate for men with hypogonadism: a systematic review and meta-analysis. In: Andrology. 2022, nr. 10, pp. 451-469. https://doi.org/10.1111/andr.13146
16. PENCINA, K.M., TRAVISON, T.G.; CUNNINGHAM, G.R. et al. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. In: The Journal of Clinical Endocrinology & Metabolism. 2024, nr. 109(2), pp. 569-580. https://doi.org/10.1210/clinem/dgad484
17. KAUFMAN, J.M. Diagnosis of hypogonadism in ageing men. In: Rev Endocr Metab Disord. 2022, nr. 23, pp. 1139- 1150.
https://doi.org/10.1007/s11154-022-09763-4
18. LEE, T.H., KIM, D.S., KIM, D.K., et al. Effect of male age on reproductive function: A comparison of young and middle-aged men. In: Investig Clin Urol. 2023, nr. 64(1), pp. 51-55. https://doi.org/10.4111/icu.20220302
19. LEISEGANG, K., SENGUPTA, P., AGARWAL, A., HENKEL, R. Obesity and male infertility: Mechanisms and management. In: Andrologia. 2021, nr. 53: e13617. https://doi.org/10.1111/and.13617
20. LEITAO, A.E., VIEIRA, M., PELEGRINI, A., GUIMARAES, A.A, 6-month, double-blind, placebo-controlled, randomized trial to evaluate the effect of Eurycoma longifolia (Tongkat Ali) and concurrent training on erectile function and testosterone levels in androgen deficiency of aging males (ADAM). In: Maturitas. 2021, nr. 145, pp. 78-85. https://doi.org/10.1016/j.maturitas.2020.12.002
21. LIANG, GUO-QING., LI, JIAN-HUI., SHI, HUI-JUAN; et al. Association of symptomatic late-onset hypogonadism and lower urinary tract symptoms in aging males: a community-based study. In: Reproductive and Developmental Medicine. 2023, nr. 7(3), pp. 129-134. https://doi.org/10.1097/RD9.0000000000000054
22. LOUTERS, M., PEARLMAN, M., SOLSRUD, E., et al. Functional hypogonadism among patients with obesity, diabetes, and metabolic syndrome. In: Int J Impot Res. 2022, nr. 34, pp. 714-720. https://doi.org/10.1038/s41443-021-00496-7
23. LUNENFELD, B., MSKHALAYA, G., ZITZMANN, M., et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. In: The Aging Male. 2015, nr. 18(1), pp. 5-15. https://doi.org/10.3109/13685538.2015.1004049
24. LUNENFELD, B., MSKHALAYA, G., KALINCHENKO, S., TISHOVA, Y. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men - a suggested update. In: The Aging Male. 2013, nr. 16(4), pp. 143-150. https://doi.org/10.3109/13685538.2013.853731
25. LUTHER, P.M., SPILLERS, N.J., TALBOT, N.C. et al. Testosterone replacement therapy: clinical considerations. In: Expert Opinion on Pharmacotherapy. 2024, nr. 25(1), pp. 25-35. https://doi.org/10.1080/14656566.2024.2306832
26. MORGENTALER, A., TRAISH, A., HACKETT, G., et al. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine. In Sexual Medicine Reviews. 2019, nr. 7(4), pp. 636-649.
https://doi.org/10.1016/j.sxmr.2019.06.003
27. MULARONI, V., ESPOSITO, V., DI PERSIO, S., et al. Age-related changes in human Leydig cell status. In: Hum Reprod. 2020, nr. 35, pp. 2663-2676. https://doi.org/10.1093/humrep/deaa271
28. MULHALL, J.P., TROST, L.W., BRANNIGAN, R.E. et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. In: Journal of Urology. 2018, nr. 200(2), pp. 423-432. https://doi.org/10.1016/j.juro.2018.03.115
29. NIESCHLAG, E. Late-onset hypogonadism: a concept comes of age. In: Andrologia. 2020, nr. 8, pp. 1506- 1511. https://doi.org/10.1111/andr.12719
30. PAPADOPOULOS, V., ZIRKIN, B. Leydig cell aging: Molecular mechanisms and treatments. In: LITWACK, G. (ed.) Vitamins and Hormones. Academic Press, 2021, nr. 115, pp. 585-609. ISSN 0083-6729 https://doi.org/10.1016/bs.vh.2020.12.023
31. PYE, S.R., HUHTANIEMI, I.T., FINN, J.D. et al. Late-Onset Hypogonadism and Mortality in Aging Men. In: The Journal of Clinical Endocrinology & Metabolism. 2014, nr. 99, pp. 1357-1366. https://doi.org/10.1210/jc.2013-2052
32. RASTRELLI, G., MAGGI, M., CORONA, G. Pharmacological management of late-onset hypogonadism. In: Expert Review of Clinical Pharmacology. 2018, nr. 11(4), pp. 439-458. https://doi.org/10.1080/17512433.2018.1445969
33. RASTRELLI, G., CORONA, G., MAGGI, M. Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction. In: Asian Journal of Andrology. 2020, nr. 22(3), pp. 265-273. https://doi.org/10.4103/aja.aja_61_19
34. ROCHIRA, V., ANTONIO, L., VANDERSCHUEREN, D. EAA clinical guideline on management of bone health, in the andrological outpatient clinic. In Andrology. 2018, nr. 6(2), pp. 272-285. https://doi.org/10.1111/andr.12470
35. SALONIA, A., BETTOCCHI, C., CARVALHO, J. EAU Guidelines on Sexual and Reproductive Health Update: Male Sexual Dysfunction. In: European Urology. 2021, nr. 80(3), pp. 333-357. https://doi.org/10.1016/j.eururo.2021.06.007
36. TAJAR, A., et al. EMAS Group. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). In: J Clin Endocrinol Metab. 2012, nr. 97, pp. 1508-1516. EISSN 1945-7197 https://doi.org/10.1210/jc.2011-2513
37. JAISWAL, V., SAWHNEY, A., NEBUWA, C. et al. Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials. In: Progress in Cardiovascular Diseases. 2024, online April. https://doi.org/10.1016/j.pcad.2024.04.001
38. WANG, C., NIESCHLAG, E., SWERDLOFF, R.S. et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. In: The Aging Male. 2009, nr. 12(1), pp. 5-12. https://doi.org/10.1080/13685530802389628
39. YEAP, B.B., GROSSMANN, M., MCLACHLAN, R.I., et al. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations. In: Med J Aust. 2016, nr. 205, pp. 228-231. https://doi.org/10.5694/mja16.00448
40. ZHANG, W., XIA, S., XIAO, W., et al. A single-cell transcriptomic landscape of mouse testicular aging. In: J Adv Res. 2022, nr. 53, pp. 219-234. https://doi.org/10.1016/j.jare.2022.12.007
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
